Headlines

Halozyme Therapeutics And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Halozyme Therapeutics (HALO), Business First Bancshares (BFST), OGE Energy Corporation (OGE) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Halozyme Therapeutics (HALO)

34.5% sales growth and 153.16% return on equity

Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous (SC) fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; XYOSTED, an injection for SC administration of testosterone replacement therapy; NOCDURNA, a sublingual tablet to treat nocturia due to nocturnal polyuria; TLANDO, an oral formulation for testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company also provides Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for the treatment of multiple blood cancer; HYQVIA to treat primary immunodeficiency disorders; and DARZALEX for patients with amyloidosis, smoldering myeloma, and multiple myeloma. In addition, it offers Epinephrine Injection to treat allergy and immunology; Sumatriptan injection for migraines; exenatide and teriparatide injections; Makena, a progestin drug to reduce the risk of preterm birth; and OTREXUP, a SC methotrexate injection for adults with severe active rheumatoid arthritis and severe recalcitrant psoriasis, as well as children with active polyarticular juvenile idiopathic arthritis. Further, the company provides ATRS-1902 for adrenal crisis rescue; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.

Earnings Per Share

As for profitability, Halozyme Therapeutics has a trailing twelve months EPS of $2.58.

PE Ratio

Halozyme Therapeutics has a trailing twelve months price to earnings ratio of 24.15. Meaning, the purchaser of the share is investing $24.15 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 153.16%.

Moving Average

Halozyme Therapeutics’s worth is higher than its 50-day moving average of $57.92 and way higher than its 200-day moving average of $45.18.

Sales Growth

Halozyme Therapeutics’s sales growth is 18.5% for the ongoing quarter and 34.5% for the next.

2. Business First Bancshares (BFST)

24.2% sales growth and 10.6% return on equity

Business First Bancshares, Inc. operates as the bank holding company for b1BANK that provides various banking products and services in Louisiana and Texas. It offers various deposit products and services, including checking, demand, money market, time, and savings accounts; and certificates of deposits, remote deposit capture, and direct deposit services. The company also provides commercial and industrial loans, such as working capital, term, equipment financing, asset acquisition, expansion and development, borrowing base, and other loan products, as well as commercial lines of credit, accounts receivable factoring, agricultural financing, and letters of credit; construction and development loans; commercial real estate loans; residential real estate loans comprising first and second lien 1-4 family mortgage loans, and home equity lines of credit; and consumer loans, including secured and unsecured installment, and term loans. In addition, it offers wealth management products, including mutual funds, annuities, individual retirement accounts, and other financial products, as well as other fiduciary and private banking products and services. Further, the company provides a range of other financial services comprising debit and credit cards, treasury and cash management, merchant, automated clearing house, lock-box, receivables factoring, correspondent banking, and other treasury services, as well as employee and payroll benefits solutions; and drive-through banking facilities, automated teller machines, night depository, personalized checks, electronic funds transfer, domestic and foreign wire transfer, traveler's checks, vault, loan and deposit sweep accounts, online and mobile banking, e-statements, and bank-by-mail services. Business First Bancshares, Inc. was founded in 2006 and is headquartered in Baton Rouge, Louisiana.

Earnings Per Share

As for profitability, Business First Bancshares has a trailing twelve months EPS of $2.42.

PE Ratio

Business First Bancshares has a trailing twelve months price to earnings ratio of 10.62. Meaning, the purchaser of the share is investing $10.62 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.6%.

Moving Average

Business First Bancshares’s value is above its 50-day moving average of $23.93 and way above its 200-day moving average of $22.35.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 21.1% and a negative 33.3%, respectively.

Sales Growth

Business First Bancshares’s sales growth is 0.2% for the current quarter and 24.2% for the next.

3. OGE Energy Corporation (OGE)

23.1% sales growth and 9.28% return on equity

OGE Energy Corp., together with its subsidiaries, operates as an energy and energy services provider that offers physical delivery and related services in the United States. It operates through Electric Company Operations and Natural Gas Midstream segments. The company generates, transmits, distributes, and sells electric energy. In addition, it provides retail electric service to approximately 889,000 customers, which covers a service area of approximately 30,000 square miles in Oklahoma and western Arkansas; and owns and operates coal-fired, natural gas-fired, wind-powered, and solar-powered generating assets. OGE Energy Corp. was founded in 1902 and is headquartered in Oklahoma City, Oklahoma.

Earnings Per Share

As for profitability, OGE Energy Corporation has a trailing twelve months EPS of $2.04.

PE Ratio

OGE Energy Corporation has a trailing twelve months price to earnings ratio of 20.08. Meaning, the purchaser of the share is investing $20.08 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.28%.

Moving Average

OGE Energy Corporation’s worth is higher than its 50-day moving average of $38.58 and way above its 200-day moving average of $35.54.

Sales Growth

OGE Energy Corporation’s sales growth is 4.1% for the ongoing quarter and 23.1% for the next.

Volume

Today’s last reported volume for OGE Energy Corporation is 1187170 which is 12.91% above its average volume of 1051420.

4. Texas Roadhouse (TXRH)

20% sales growth and 31.96% return on equity

Texas Roadhouse, Inc., together with its subsidiaries, operates casual dining restaurants in the United States and internationally. The company operates and franchises Texas Roadhouse and Bubba's 33 restaurants. As of December 29, 2020, it operated 537 domestic restaurants and 97 franchise restaurants. Texas Roadhouse, Inc. was founded in 1993 and is based in Louisville, Kentucky.

Earnings Per Share

As for profitability, Texas Roadhouse has a trailing twelve months EPS of $5.52.

PE Ratio

Texas Roadhouse has a trailing twelve months price to earnings ratio of 30.74. Meaning, the purchaser of the share is investing $30.74 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.96%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Sep 4, 2024, the estimated forward annual dividend rate is 2.38 and the estimated forward annual dividend yield is 1.4%.

Volume

Today’s last reported volume for Texas Roadhouse is 1312050 which is 69.48% above its average volume of 774160.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 36.8% and 42.6%, respectively.

Yearly Top and Bottom Value

Texas Roadhouse’s stock is valued at $169.71 at 11:22 EST, under its 52-week high of $177.72 and way above its 52-week low of $91.06.

5. iRadimed Corporation (IRMD)

10.4% sales growth and 25.08% return on equity

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

Earnings Per Share

As for profitability, iRadimed Corporation has a trailing twelve months EPS of $1.46.

PE Ratio

iRadimed Corporation has a trailing twelve months price to earnings ratio of 33.52. Meaning, the purchaser of the share is investing $33.52 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.08%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 11.2%, now sitting on 69.48M for the twelve trailing months.

Yearly Top and Bottom Value

iRadimed Corporation’s stock is valued at $48.94 at 11:22 EST, under its 52-week high of $50.93 and way higher than its 52-week low of $36.12.

Moving Average

iRadimed Corporation’s value is above its 50-day moving average of $45.94 and way above its 200-day moving average of $44.11.

6. Chemed Corp (CHE)

10% sales growth and 27.87% return on equity

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Earnings Per Share

As for profitability, Chemed Corp has a trailing twelve months EPS of $19.71.

PE Ratio

Chemed Corp has a trailing twelve months price to earnings ratio of 28.78. Meaning, the purchaser of the share is investing $28.78 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.87%.

Yearly Top and Bottom Value

Chemed Corp’s stock is valued at $567.22 at 11:22 EST, way below its 52-week high of $654.62 and way higher than its 52-week low of $492.84.

Volume

Today’s last reported volume for Chemed Corp is 43882 which is 52.97% below its average volume of 93312.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Aug 12, 2024, the estimated forward annual dividend rate is 2 and the estimated forward annual dividend yield is 0.35%.

7. Matson (MATX)

6.7% sales growth and 14.15% return on equity

Matson, Inc., together with its subsidiaries, provides ocean transportation and logistics services. The company's Ocean Transportation segment offers ocean freight transportation services to the domestic non-contiguous economies of Hawaii, Alaska, and Guam, as well as to other island economies in Micronesia. It primarily transports dry containers of mixed commodities, refrigerated commodities, packaged foods and beverages, building materials, automobiles, and household goods; livestock; seafood; general sustenance cargo; and garments, footwear, e-commerce, and other retail merchandise. This segment also operates an expedited service from China to Long Beach, California, and various islands in the South Pacific, as well as Okinawa, Japan; and provides container stevedoring, refrigerated cargo services, inland transportation, container equipment maintenance, and other terminal services to ocean carriers on the Hawaiian islands of Oahu, Hawaii, Maui, and Kauai, as well as in the Alaska locations of Anchorage, Kodiak, and Dutch Harbor. In addition, it offers vessel management services. The Logistics segment provides multimodal transportation brokerage services, including domestic and international rail intermodal, long-haul and regional highway trucking, specialized hauling, flat-bed and project, less-than-truckload, and expedited freight services; less-than-container load consolidation and freight forwarding services; warehousing and distribution services; and supply chain management services. It serves the U.S. military, freight forwarders, retailers, consumer goods, automobile manufacturers, and other customers. The company was formerly known as Alexander & Baldwin Holdings, Inc. and changed its name to Matson, Inc. in June 2012. Matson, Inc. was founded in 1882 and is headquartered in Honolulu, Hawaii.

Earnings Per Share

As for profitability, Matson has a trailing twelve months EPS of $9.46.

PE Ratio

Matson has a trailing twelve months price to earnings ratio of 14.02. Meaning, the purchaser of the share is investing $14.02 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.15%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 39.4% and 37.1%, respectively.

Volume

Today’s last reported volume for Matson is 225736 which is 22.41% below its average volume of 290959.

8. Verra Mobility Corporation (VRRM)

5.4% sales growth and 21.4% return on equity

Verra Mobility Corporation provides smart mobility technology solutions and services in the United States, Canada, and Europe. It operates through two segments, Government Solutions and Commercial Services. The Government Solutions segment offers automated safety solutions, including services and technologies that enable photo enforcement through road safety camera programs, which detects and process traffic violations related to red light, speed, school bus, and city bus lanes. This segment serves municipalities, counties, school districts, and law enforcement agencies. The Commercial Services segment provides automated toll and violations management, and title and registration solutions to rental car companies, fleet management companies, and other large fleet owners. The company is headquartered in Mesa, Arizona.

Earnings Per Share

As for profitability, Verra Mobility Corporation has a trailing twelve months EPS of $0.58.

PE Ratio

Verra Mobility Corporation has a trailing twelve months price to earnings ratio of 44.57. Meaning, the purchaser of the share is investing $44.57 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.4%.

Volume

Today’s last reported volume for Verra Mobility Corporation is 311271 which is 72.28% below its average volume of 1123200.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 10.3% and 29.2%, respectively.

Leave a Reply

Your email address will not be published. Required fields are marked *